查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1863166

全球超音波设备市场：洞察、竞争格局及至2032年预测

Ultrasound Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

超音波设备市场摘要

  • 全球超音波设备市场预计将从 2024 年的 93.1506 亿美元成长到 2032 年的 130.5468 亿美元，反映出强劲且持续的成长。
  • 全球超音波设备市场在 2025 年至 2032 年的预测期内将以 4.38% 的复合年增长率成长。
  • 全球超音波设备市场正蓬勃发展，这主要得益于人们对早期精准诊断的需求不断增长、微创手术应用日益广泛，以及3D/4D成像、人工智慧和可携式系统技术的进步。此外，超音波设备在成本效益、安全性以及包括产科、循环系统和慢性病管理在内的广泛应用，也进一步推动了其普及。新兴市场医疗服务可近性的提高也为市场成长提供了助力。
  • 超音波设备市场的主要企业包括：GE医疗、西门子医疗、佳能医疗系统株式会社、深圳迈瑞生物医疗电子股份有限公司、日立有限公司、BPL医疗技术公司、SonoScape医疗公司、Butterfly Network公司、Carestream Health公司、Clarius Mobile Health公司、Trivitron Healthcare公司、Chison Medical Imaging 公司、Carestream Health公司、Clarius Mobile Health、Trivitron Healthcare公司、Chison Medical Imaging Co.L. Imaging公司。
  • 北美超音波设备市场持续成长，这主要得益于其完善的医疗基础设施、先进成像技术的广泛应用以及主要医疗设备製造商的强大实力。心血管疾病、癌症和肝病等慢性疾病的日益普遍，推动了对早期精准影像诊断的需求。此外，该地区还受益于有利的医疗保险政策、不断上涨的医疗成本以及日益增强的预防保健意识。人工智慧超音波和可携式床边诊断系统等持续的产品创新，进一步推动了医院和门诊中心对超音波设备的应用。此外，人口老化以及超音波在妇科、心臟病学和急诊护理等领域的日益普及，也推动了该市场的强劲成长。
  • 根据产品类型划分，超音波设备市场预计将以二维超音波设备为主，预计到 2024 年，二维超音波设备将占据最大的市场份额。

超音波设备市场成长要素

  • 慢性病盛行率上升推动超音波设备市场快速扩张。心血管疾病、癌症和肝损伤等慢性病盛行率的上升是推动市场成长的主要因素。由于其非侵入性和即时性，超音波已成为诊断、监测和管理这些疾病的重要工具。
  • 人们越来越偏好非侵入性、安全的诊断方法：与X光和电脑断层扫描不同，超音波不使用电离辐射，因此更安全，尤其适用于孕妇、儿童等敏感人群，或用于慢性病监测。这种固有的安全性使其成为首选的影像学检查方式。
  • 技术进步：这可以说是最重要的驱动因素。技术创新使超音波系统更强大、用途更广泛、更易于使用。
  • 小型化和便携性：小型便携式超音波设备（通常称为床边超音波，POCUS）的开发是一项突破。这些设备，其中一些可以连接到智慧型手机或平板电脑，能够在患者床边、急诊室、救护车上以及偏远和农村地区进行即时成像，大大扩展了超音波检查的覆盖范围。
  • 人工智慧（AI）整合：人工智慧和机器学习演算法正被整合到超音波系统中，以提高影像品质、实现测量自动化并辅助诊断。人工智慧可以帮助经验不足的使用者获得高品质影像，并标记潜在的异常情况以进行进一步检查，从而提高诊断的准确性和效率。
  • 影像处理：高解析度 3D 和即时 4D 成像、弹性成像（测量组织硬度以检测肿瘤和肝纤维化）以及造影超音波(CEUS) 等成像技术的进步，提供了更详细、更准确的诊断资讯。
  • 无线连接和远端超音波：无线换能器和云端基础的平台可以即时传输和共用影像，用于远端会诊和即时指导。

超音波设备市场报告细分

本超音波设备市场报告全面概​​述了全球超音波设备市场，重点分析了关键趋势、成长驱动因素、挑战和机会。报告按产品类型、设备显示、便携性、应用、最终用户和地区进行了详细的市场细分。报告深入分析了北美、欧洲和亚太等主要市场的竞争格局、监管环境和市场动态。透过对产业领导者及其最新产品开发的详细介绍，本报告为企业提供了识别市场潜力、制定策略规划以及把握快速成长的超音波设备市场新机会所需的重要数据。

超音波设备是一种医学影像工具，它利用高频声波即时产生人体内部影像。与X光不同，它不使用电离辐射，因此可以安全、非侵入性地观察软组织和器官，例如心臟、肝臟、肾臟和胎儿。

全球超音波设备市场正因慢性病盛行率上升、对早期精准诊断的需求不断增长以及微创手术的日益普及而蓬勃发展。超音波技术的进步，例如3D/4D成像、人工智慧整合和携带式手持系统，进一步推动了其在医院、诊断中心和照护现场环境中的应用。人们对孕产妇保健意识的提高以及人口老化也推动了产科和循环系统对超音波的需求。此外，与其他影像学检查方式相比，超音波具有成本效益高、安全且无辐射等优点，因此成为更受欢迎的诊断工具。新兴市场医疗基础设施的不断改进以及政府为提升诊断影像服务可近性而推出的利好政策，也进一步促进了市场成长。

全球超音波设备市场正因对早期精准诊断的需求不断增长、微创手术应用日益广泛以及3D/4D成像、人工智慧和可携式系统的进步而持续扩张。这项扩张的根本驱动力在于技术创新、全球人口老化以及慢性病负担日益加重等因素的共同作用。例如，世界卫生组织（WHO）的数据显示，2019年慢性病约占全球整体所有死亡人数的74%，较2010年的67%显着上升。这一令人担忧的趋势，加上慢性病患病率的不断攀升——仅心血管疾病就影响着全球超过5.23亿人——以及预计到2040年癌症病例将增长近50%，共同造就了对安全、非侵入性诊断成像技术的持续需求。

作为一种无辐射的检查方式，超音波越来越受到人们的青睐，用于常规检查、早期筛检和长期监测这些疾病，直接应对这项公共卫生挑战。

此外，全球老年人口不断增长，其中相当一部分60岁及以上人群患有至少一种慢性疾病，这是推动需求成长的主要人口因素。 2019年，60岁及以上人口数量约为10亿，预计到2030年将达到约14亿，到2050年将达到约21亿，这将增加对筛检和诊断的需求。

市场成长也得益于技术的微型化，促使携带式和手持式超音波设备迅速普及。这使得超音波从医院的固定工具转变为功能多样的床边诊断解决方案，普及了诊断影像服务。智慧型手机的普及为这些小型装置创造了庞大的用户群体，全球智慧型手机用户超过72亿，其中许多装置可以直接连接到智慧型手机进行即时影像显示。

人工智慧和机器学习的融合进一步放大了这一效应。人工智慧系统能够自动优化影像品质、进行测量并辅助诊断，使超音波更容易被未经训练的专业人员使用。开发中国家，特别是亚太地区的发展中国家，不断增加医疗保健支出和基础设施投资，对经济高效的诊断解决方案的需求预计将持续成长，从而确保全球市场的扩张。

这些流行病学、人口统计和技术趋势正在加速医院、诊所和社区医疗保健机构采用诊断性超音波，从而支持强劲的市场成长。

儘管超音波设备市场成长强劲，但仍面临许多限制和挑战，主要原因在于高成本和熟练专业人员的短缺。先进系统所需的初始投资高达数万至数十万美元，这对开发中国家的小型诊所和医疗机构而言仍然是一大障碍。持续的维护和保养成本加剧了这一经济负担，常常迫使医疗机构选择价格更低的翻新产品或推迟关键的技术升级。第二个同样重要的挑战是全球训练有素的超音波和放射科医师的短缺。超音波设备的有效性高度依赖操作者的技能，即使配备最先进的设备，合格人员的短缺也可能导致诊断错误。超音波的需求成长速度超过了供应速度，导致现有职位与新毕业生人数之间存在巨大差距。这种短缺导致患者等待时间过长，给现有专业人员带来巨大压力，并增加了职业倦怠的风险。此外，该市场受到包括美国FDA和欧盟在内的监管机构的严格监管，这可能会延迟产品上市并增加製造商的成本。最后，该市场的寡占性质，即由少数几家大型企业主导，会造成激烈的竞争和价格压力，限制规模较小、具有创新精神的企业进入市场并取得成功的能力。

超音波设备市场細項分析超音波诊断

设备市场按产品类型、设备展示、便携性、应用和地区划分

超音波设备市场区域分析

北美超音波设备市场趋势

以美国主导的北美地区，预计2024年将占据全球超音波设备市场35%的份额。北美是全球超音波市场的主要成长引擎，这主要得益于高昂的医疗成本、床边超音波（POCUS）的快速普及以及慢性病负担沉重，这些因素共同推动了对诊断成像和监测的需求。预计到2024年，北美将占据全球POCUS市场约三分之一的份额，反映出急诊室、基层医疗和门诊等场所对床边照护现场的广泛应用。

该地区的流行病学特征正在推动需求：仅在美国，2023年死于心臟病的人数就将达到约919,032人，这将维持较高的心臟影像和多普勒检查使用率。人口趋势也是关键因素：预计到2024年，美国65岁以上人口将达到6,120万，这将增加对筛检、慢性病追踪和老年影像检查的需求。

技术进步和人工智慧正在加速普及，製造商们推出了功能更强大的固定式和即时检测系统，这些系统配备了人工智慧工作流程工具，例如GE医疗的新型Vivid Pioneer心血管超音波（已获得CE/FDA 510(k)认证）和飞利浦最近推出的Flash 5100即时检测系统，所有这些系统的目标床旁成像，更准确的医院吞吐量提高的医院吞吐量。

最后，治疗性超音波的监管核准不断增加，以及对远端超音波和智慧型手机连接探头的投资，正在扩大临床应用案例（从常规产前扫描到紧急心臟分诊），从而支持北美对市场成长的重大贡献。

欧洲超音波设备市场趋势

欧洲超音波设备市场在全球占据领先地位，市场份额显着，这主要得益于先进的医疗基础设施和对高效诊断工具的旺盛需求。其中一个最显着的趋势是可携式手持超音波设备的日益普及，其在急诊、基层医疗诊所甚至居家照护等照护现场的应用也日益广泛。这直接响应了人们对更快、更便捷的诊断的需求，而远端医疗的兴起进一步推动了这一趋势。此外，欧洲人口老化及其导致的心血管疾病和癌症等慢性病发病率上升也对市场产生了显着影响。超音波的非侵入性和即时监测功能使其成为管理这些慢性疾病的理想工具。

此外，欧洲医疗保健系统正积极拥抱科技创新。人工智慧 (AI) 的应用已成为一种强劲的趋势，旨在提升影像品质、实现测量自动化并提高诊断准确性，有助于缓解熟练超音波医师短缺的挑战。儘管诊断超音波仍然是最大的细分市场，但治疗性超音波市场，尤其是超音波高强度聚焦超音波(HIFU)，已成为一个关键的成长领域，这主要得益于人们对非侵入性治疗方案日益增长的关注。儘管成长强劲，但该市场仍面临诸多挑战，例如欧盟医疗设备法规 (MDR) 等严格的法律规范，以及来自价格较亲民的中国供应商（尤其是在价格分布市场）带来的价格下行压力。

亚太地区超音波设备市场趋势

亚太地区超音波设备市场预计将成为全球成长最快的区域市场，中国和日本将引领这一市场成长，其驱动因素包括人口成长和老化、经济快速发展以及医疗保健成本上升等独特因素。

该地区的医疗保健状况的特征是慢性病和非传染性疾病（如心血管疾病和癌症）的盛行率很高。

此外，政府为改善都市区地区的医疗基础设施和可近性所做的努力也发挥了关键作用，包括促进医疗设备的国内生产，尤其是在中国和印度，这促成了经济实惠的超音波系统的生产。

儘管GE医疗和西门子医疗等老牌厂商占据着强大的市场地位，但迈瑞医疗和佳能医疗系统等以创新和价格分布竞争力着称的区域性主要厂商也在积极塑造着市场格局。此外，该地区多元化的医疗基础设施和分散的人口分布也促使可携式和手持式超音波设备迅速普及，这些设备非常适合满足照护现场诊断需求。

这些公司总合占据最大的市场份额，并引领产业趋势。

  • GE HealthCare
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Canon Medical Systems Corporation
  • Samsung Healthcare
  • FUJIFILM Holdings Corporation
  • Esaote SpA
  • Hologic, Inc.
  • Hitachi, Ltd
  • BPL Medical Technologies
  • SonoScape Medical Corporation
  • Butterfly Network, Inc.
  • Carestream Health
  • Clarius Mobile Health
  • Trivitron Healthcare
  • Chison Medical Imaging Co., Ltd.
  • Teratech Corporation
  • Wuhan Zoncare Bio-medical Electronics Co., Ltd.
  • SuperSonic Imagine
  • DMS Imaging
  • 其他的

超音波设备市场的竞争格局瞬息万变，市场集中度中等至较高。该市场由几家大型、成熟的跨国公司主导，通常被称为「四大巨头」：通用电气医疗集团（GE Healthcare）、皇家飞利浦公司（Koninklijke Philips NV）、西门子医疗（Siemens Healthineers）和佳能医疗系统公司（Canon Medical Systems Corporation）。这些公司凭藉着强大的品牌知名度、广泛的全球分销网络以及雄厚的研发投入，保持着市场主导地位。例如，通用电气医疗集团（GE Healthcare）凭藉其在女性健康领域的领先地位，特别是其Voluson系列产品，估计占据了相当大的全球市场份额。

然而，这种竞争动态正受到新一波创新企业的挑战。迈瑞医疗国际有限公司和三星麦迪逊等公司正透过提供兼具先进技术和极具竞争力的价格的产品，迅速扩大市场份额，尤其是在新兴市场。此外，富士胶片Sonosite和Butterfly Network等专业製造商的崛起，正透过专注于携带式手持超音波设备，直接与传统的推车式系统展开竞争，重塑市场格局。这加剧了竞争，并推动了一场技术创新竞赛，迫使所有企业整合人工智慧、增强型影像处理和云端连接等最尖端科技，以实现产品差异化并巩固市场地位。

  • 2025 年 8 月，Esaote 的紧凑型平台 MyLab™ A50 和 MyLab™ A70 获得 FDA 批准，作为具有先进影像处理和人工智慧功能的电池供电可携式系统进入美国。
  • 2025 年 8 月，飞利浦宣布在全球推出 Flash 5100 POC超音波系统，照护现场设备。
  • 2025 年 6 月，Exo 扩展了其手持式 Exo Iris® 的临床功能，获得了 FDA 510(k) 许可，可在设备上使用 AI 来检测胸腔积液和实变，从而推进了 AI 赋能的 POCUS 诊断。
  • 2025 年 5 月，Exo Imaging 和三星麦迪逊宣布建立策略合作伙伴关係，包括三星的投资，共同开发下一代超音波平台。
  • 2025 年 4 月，Exo 在其 Exo Iris®（已获 FDA已经过核准）中增加了即时全局纵向应变 (GLS) 分析，使其成为第一款可在床边进行心臟评估的装置端 GLS 手持装置。
  • 2025 年 4 月，飞利浦推出了 EPIQ Elite（以及相关的 Affiniti 平台）的 Elevate AI 平台升级，引入了自动影像优化和工作流程工具，以加快检查速度并提高诊断一致性。
  • 2025 年 1 月，三星麦迪逊在美国推出了高阶妇产科系统 HERA/Z20（在 SMFM 2025 上首次亮相）。
  • 2025 年 1 月，Hologic 以 3.5 亿美元的价格完成了对 Gynesonics 的收购，Gynesonics 是 Sonata 系统（超音波导引系统）的开发商。

超音波设备市场细分

  • 按产品类型分類的超音波设备市场趋势
  • 2D
  • 3D/4D
  • 多普勒
  • 高强度聚焦超音波（HIFU）
  • 超音波设备显示器曝光
  • 彩色超音波
  • 黑白超音波
  • 超音波设备便携性
  • 固定式
  • 可携式的
  • 按设备分類的超音波设备市场趋势
  • 妇科
  • 循环系统
  • 泌尿系统
  • 整形外科
  • 其他的
  • 按最终用户分類的超音波设备市场趋势
  • 医院
  • 诊断中心
  • 诊所
  • 门诊手术中心
  • 其他的
  • 各地区超音波设备市场趋势
  • 北美超音波设备市场
  • 美国超音波设备市场
  • 加拿大超音波设备市场
  • 墨西哥超音波设备市场
  • 欧洲超音波设备市场
  • 英国超音波设备市场
  • 德国超音波设备市场
  • 法国超音波设备市场
  • 义大利超音波设备市场
  • 西班牙超音波设备市场
  • 其他欧洲超音波设备市场
  • 亚太超音波设备市场
  • 中国超音波设备市场
  • 日本超音波设备市场
  • 印度超音波设备市场
  • 澳洲超音波设备市场
  • 韩国超音波设备市场
  • 亚太地区其他超音波设备市场
  • 世界其他地区超音波设备市场
  • 南美洲超音波设备市场
  • 中东超音波设备市场
  • 非洲超音波设备市场

利用人工智慧进行影响分析

人工智慧 (AI) 的融合正在为超音波设备市场带来变革性影响，从根本上重塑其功能并扩大其应用范围。 AI 驱动的创新透过自动化耗时且依赖操作人员的任务，有效应对了长期存在的挑战，显着提升了工作流程的效率和准确性。例如，AI 演算法可以自动撷取和分析影像，使临床医生能够专注于与患者的互动，并缩短检查时间。

此外，人工智慧可以作为强大的诊断辅助工具，透过检测细微异常和辅助病灶分类，提高诊断准确率并降低人为错误风险。然而，人工智慧最大的影响或许在于其对超音波检查普及化的推动作用。人工智慧引导系统能够提供使用者即时、逐步的回馈，让经验不足的医护人员也能进行高品质的诊断扫描。这正是照护现场超音波（POCUS）市场爆炸性成长的关键因素，使其应用范围不断扩大，涵盖诊所、偏远地区和急诊环境。儘管面临高成本和需要大量高品质资料集来训练人工智慧模型等挑战，但超音波技术的未来与人工智慧密不可分，人工智慧将持续提升其效用，并重新定义其在全球医疗保健领域的角色。

美国关税对超音波设备市场的影响分析

对来自美国，尤其是来自中国和欧盟的医疗设备及零件征收关税，对全球超音波设备市场构成重大且多方面的挑战。这些关税可能大幅增加进口成本，直接挤压製造商的利润空间，或迫使其将这些增加的成本转嫁给医疗机构，最终转嫁给患者，因为医院和诊所，尤其是规模较小的医院和诊所，可能难以购买资本密集型设备。

此外，关税会扰乱既有的复杂全球供应链，迫使企业迅速寻找新的供应商或考虑外包生产以避免额外成本。这会导致供不应求、物流延误、营运成本增加和市场不稳定。虽然关税旨在鼓励国内生产，从长远来看减少对海外供应商的依赖，但由于企业优先考虑成本控製而非新产品开发，关税也可能导致研发投入减少，并扼杀创新。此外，受影响国家可能采取报復性关税措施，进一步损害美国医疗设备出口，使竞争格局更加复杂。

  • 成本管理：了解关税环境可以让客户预测成本上涨，并据此调整定价策略，确保盈利。
  • 供应链优化：可以确定替代采购方案，实现供应链多元化，以减少对高关税地区的依赖，并提高韧性。
  • 监管导航：在不断变化的法规环境中，专家指导可协助您保持合规并避免潜在的法律挑战。
  • 策略规划洞察关税的影响使客户能够就製造地、伙伴关係和打入市场策略做出明智的决策。

目录

第一章超音波设备市场报告概述

  • 调查范围
  • 市场区隔
  • 市场假设

第二章超音波设备市场执行摘要

  • 市场概览

第三章：超音波设备

  • 市场驱动因素
    • 慢性病盛行率上升
    • 人们对非侵入性和更安全的诊断方法越来越感兴趣
    • 技术进步
    • 对照护现场（POCUS）的需求不断增长
    • 拓展至超音波
  • 市场限制与挑战
    • 超音波系统高成本
    • 严格的规章制度和报销政策
    • 可携式和手持式超音波设备面临的挑战
  • 市场机会
    • 人工智慧（AI）与机器学习（ML）的融合

第四章 影响分析

  • 人工智慧驱动的创新和应用
  • 美国关税的影响分析

第五章 监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第六章超音波设备市场：波特五力分析

第七章超音波设备市场评估

  • 依产品类型
    • 2D
    • 3D/4D
    • 多普勒
    • 高强度聚焦超音波（HIFU）
  • 透过设备显示
    • 彩色超音波
    • 黑白超音波
  • 透过便携性
    • 固定式
    • 可携式的
  • 透过使用
    • 妇科
    • 心臟病学
    • 泌尿系统
    • 整形外科
    • 其他的
  • 最终用户
    • 医院
    • 诊断中心
    • 诊所
    • 门诊手术中心
  • 地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 其他地区

第八章 竞争情势

第九章Start-Ups资金筹措与投资趋势

第十章超音波设备市场 公司及产品概况

  • GE HealthCare
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Canon Medical Systems Corporation
  • Samsung Healthcare
  • FUJIFILM Holdings Corporation
  • Esaote SpA
  • Hologic, Inc.
  • Hitachi, Ltd
  • BPL Medical Technologies
  • SonoScape Medical Corporation
  • Butterfly Network, Inc.
  • Carestream Health
  • Clarius Mobile Health
  • Trivitron Healthcare
  • Chison Medical Imaging Co., Ltd.
  • Teratech Corporation
  • Wuhan Zoncare Bio-medical Electronics Co., Ltd.
  • SuperSonic Imagine
  • DMS Imaging

第十一章：KOL视角

第十二章计划方法

第十三章：关于 DelveInsight

第十四章 免责声明和联络我们

Product Code: DIMDCL0298

Ultrasound Devices Market Summary

  • The global ultrasound devices market is expected to increase from USD 9,315.06 million in 2024 to USD 13,054.68 million by 2032, reflecting strong and sustained growth.
  • The global ultrasound devices market is growing at a CAGR of 4.38% during the forecast period from 2025 to 2032.
  • The global ultrasound device market is growing due to rising demand for early and accurate diagnosis, increasing use in minimally invasive procedures, and advancements like 3D/4D imaging, AI, and portable systems. Its cost-effectiveness, safety, and wide applications in obstetrics, cardiology, and chronic disease management further boost adoption. Expanding healthcare access in emerging markets also supports growth.
  • The leading companies operating in the ultrasound devices market include GE HealthCare, Siemens Healthineers, Canon Medical Systems Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Canon Medical Systems Corporation, Samsung Healthcare, FUJIFILM Holdings Corporation, Esaote SpA, Hologic, Inc., Hitachi, Ltd, BPL Medical Technologies, SonoScape Medical Corporation, Butterfly Network, Inc., Carestream Health, Clarius Mobile Health, Trivitron Healthcare, Chison Medical Imaging Co., Ltd., Teratech Corporation, Wuhan Zoncare Bio-medical Electronics Co., Ltd., SuperSonic Imagine, DMS Imaging, and Others.
  • The North American ultrasound device market is dominating and growing due to its well-established healthcare infrastructure, high adoption of advanced imaging technologies, and strong presence of leading medical device manufacturers. The rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and liver diseases is driving demand for early and accurate diagnostic imaging. The region also benefits from favorable reimbursement policies, higher healthcare expenditure, and growing awareness of preventive healthcare. Continuous product innovations, such as AI-powered ultrasound and portable point-of-care systems, are further fueling adoption across hospitals and outpatient centers. In addition, the aging population and increasing use of ultrasound in women's health, cardiology, and emergency medicine are reinforcing the market's strong growth trajectory.
  • In the product type segment of the ultrasound devices market, the 2D category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Ultrasound Devices Market

  • Rising prevalence of chronic diseases leading to a surge in the ultrasound devices market: The increasing incidence of chronic diseases such as cardiovascular conditions, cancer, and liver disorders is a major market driver. Ultrasound is a vital tool for the diagnosis, monitoring, and management of these conditions due to its non-invasive and real-time nature.
  • Growing Preference for Non-Invasive and Safer Diagnostics: Ultrasound does not use ionizing radiation, unlike X-rays or CT scans. This makes it a safer option for repeated use, particularly for sensitive patients like pregnant women and children, as well as for monitoring chronic conditions. This inherent safety profile makes it a preferred imaging modality.
  • Advancement in Technology: This is arguably the most significant driver. Innovations have made ultrasound systems more powerful, versatile, and accessible:
  • Miniaturization and Portability: The development of compact, portable, and handheld ultrasound devices (often called Point-of-Care Ultrasound or POCUS) is a game-changer. These devices, some of which connect to smartphones or tablets, allow for real-time imaging at the patient's bedside, in emergency rooms, ambulances, and remote or rural areas, dramatically expanding the reach of ultrasound.
  • Integration of Artificial Intelligence (AI): AI and machine learning algorithms are being integrated into ultrasound systems to improve image quality, automate measurements, and assist in diagnosis. AI can help less experienced users acquire high-quality images and can flag potential abnormalities for further review, increasing diagnostic accuracy and efficiency.
  • Enhanced Imaging Capabilities: Advancements in imaging technology, such as high-resolution 3D and real-time 4D imaging, elastography (which measures tissue stiffness to detect tumors and liver fibrosis), and contrast-enhanced ultrasound (CEUS), provide more detailed and accurate diagnostic information.
  • Wireless Connectivity and Tele-Ultrasound: Wireless transducers and cloud-based platforms enable images to be transmitted and shared instantly for remote consultations and real-time guidance, which is crucial for telemedicine and remote healthcare delivery.

Ultrasound Devices Market Report Segmentation

This ultrasound devices market report offers a comprehensive overview of the global ultrasound devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (2D, 3D/4D, Doppler, and High-Intensity Focused Ultrasound (HIFU)), Device Display (Color Ultrasound, B/W Ultrasound), Portability (Stationary, Portable), Application (Gynecology, Cardiology, Urology, Orthopedic, and Others), End-Users (Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Centers, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing ultrasound devices market.

An ultrasound device is a medical imaging tool that uses high-frequency sound waves to create real-time images of the inside of the body. Unlike X-rays, it does not use ionizing radiation, making it a safe and non-invasive way to visualize soft tissues and organs, such as the heart, liver, kidneys, and an unborn baby.

The global ultrasound device market is growing due to the rising prevalence of chronic diseases, increasing demand for early and accurate diagnosis, and the expanding use of minimally invasive procedures. Advancements in ultrasound technology, such as 3D/4D imaging, AI integration, and portable handheld systems, are further driving adoption across hospitals, diagnostic centers, and point-of-care settings. Growing awareness of prenatal care and maternal health, coupled with the aging population, has also boosted demand for ultrasound in obstetrics and cardiology. Additionally, ultrasound is cost-effective, safe, and radiation-free compared to other imaging modalities, making it a preferred diagnostic tool. Expanding healthcare infrastructure in emerging markets and favorable government initiatives to enhance access to imaging services are further contributing to market growth.

What are the latest Ultrasound Devices Market Dynamics and Trends?

The global ultrasound device market is growing due to rising demand for early and accurate diagnosis, increasing use in minimally invasive procedures, and advancements like 3D/4D imaging, AI, and portable systems. This expansion is fundamentally driven by a confluence of technological innovation, an aging global population, and the escalating burden of chronic diseases. For instance, according to the World Health Organization, chronic diseases were responsible for approximately 74% of all deaths worldwide in 2019, a significant increase from 67% in 2010. This alarming trend, rising chronic disease prevalence, with cardiovascular disease alone impacting over 523 million people globally, and cancer cases projected to increase by nearly 50% by 2040, is creating sustained demand for safe and non-invasive imaging.

Ultrasound, being a radiation-free modality, is increasingly preferred for routine check-ups, early screening, and long-term monitoring of such conditions, directly addressing this public health challenge.

Furthermore, the global rise of the geriatric population, with a significant percentage of individuals aged 60 and above having at least one chronic condition, is a major demographic factor fueling demand. The number of people aged 60+ was about 1 billion in 2019 and is projected to reach ~1.4 billion by 2030 and 2.1 billion by 2050, increasing screening and diagnostic needs.

The market's growth is also being supercharged by the miniaturization of technology, leading to the proliferation of portable and handheld ultrasound devices. This has democratized access to imaging by transforming ultrasound from a static, hospital-based tool into a versatile, point-of-care solution. The widespread adoption of smartphones, with over 7.2 billion active subscriptions globally, has created a massive user base for these compact devices, as many can connect directly to a smartphone for a real-time display. This technical synergy with common consumer technology is enabling healthcare providers to perform quick and accurate diagnostics in a variety of settings, from a rural clinic to an ambulance, leading to faster treatment decisions and improved patient outcomes.

The integration of artificial intelligence and machine learning is further amplifying this effect, as AI-powered systems can automatically optimize image quality, perform measurements, and assist in diagnosis, making ultrasound even more accessible to professionals with limited training. As developing nations, particularly in the Asia-Pacific region, increase their healthcare spending and infrastructure investment, the demand for these affordable and effective diagnostic solutions will continue to accelerate, solidifying the market's global expansion.

Together, these epidemiologic, demographic, and technological trends are accelerating ultrasound adoption across hospitals, clinics, and community care, supporting robust market growth.

Despite the robust growth, the ultrasound devices market faces significant restraints and challenges, primarily stemming from high costs and the shortage of skilled professionals. The high initial investment required for advanced systems, which can range from tens to hundreds of thousands of dollars, remains a major barrier for smaller clinics and healthcare providers in developing countries. This financial hurdle is compounded by ongoing maintenance and servicing costs, often forcing institutions to opt for more affordable, refurbished equipment or to delay crucial technology upgrades. A second, equally critical challenge is the global shortage of trained sonographers and radiologists. The effectiveness of an ultrasound device is highly dependent on the operator's skill, and a lack of qualified personnel can lead to diagnostic errors, even with the most advanced machines. The demand for sonographers is increasing faster than the supply, with a significant gap between the number of open positions and the number of graduates entering the workforce. This shortage contributes to longer patient wait times and places a heavy workload on existing professionals, increasing the risk of burnout. Additionally, the market is subject to stringent regulatory hurdles from agencies like the U.S. FDA and the EU, which can delay product launches and increase costs for manufacturers. Finally, the market's oligopolistic nature, dominated by a few large companies, creates intense competition and price pressure, which can limit the ability of smaller, innovative players to enter and thrive in the market.

Ultrasound Devices Market Segment Analysis

Ultrasound Devices Market by Product Type Product Type (2D, 3D/4D, Doppler, and High-Intensity Focused Ultrasound (HIFU)), Device Display (Color Ultrasound, B/W Ultrasound), Portability (Stationary, Portable), Application (Gynecology, Cardiology, Urology, Orthopedic, and Others), End-Users (Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Ultrasound Devices Market Regional Analysis

North America Ultrasound Devices Market Trends

North America, led by the U.S., accounted for a dominant ~35% share of the global ultrasound devices market in 2024. North America is a key growth engine for the global ultrasound market thanks to high healthcare spending, rapid POCUS adoption, and a large burden of chronic disease that drives demand for imaging and monitoring. North America held roughly one-third of the POCUS market in 2024, underscoring strong point-of-care uptake across ERs, primary care, and ambulatory settings.

The region's epidemiology amplifies demand; heart disease alone caused about 919,032 deaths in the U.S. in 2023, keeping cardiac imaging and Doppler use high. Demographics also matter: the U.S. population aged 65+ reached ~61.2 million in 2024, expanding screening, chronic-care follow-up, and geriatric imaging needs.

Technological advances and AI are accelerating uptake, and manufacturers are rolling out higher-performance stationary and POC systems with AI workflow tools, exemplified by GE HealthCare's new Vivid Pioneer cardiovascular ultrasound (CE/FDA 510(k) cleared) and Philips' recent Flash 5100 POC launch, both aimed at faster, more accurate bedside imaging and higher throughput in hospitals.

Finally, increasing regulatory approvals for therapeutic ultrasound and investments in tele-ultrasound and smartphone-connected probes are broadening clinical use cases (from routine prenatal scans to emergency cardiac triage), which together sustain North America's outsized contribution to market growth.

Europe Ultrasound Devices Market Trends

The European ultrasound devices market is a major global player, holding a significant share driven by its advanced healthcare infrastructure and a high demand for efficient diagnostic tools. One of the most prominent trends is the rising adoption of portable and handheld ultrasound devices, which are increasingly being used in point-of-care settings like emergency rooms, primary care clinics, and even home care. This is a direct response to the need for faster, more accessible diagnostics and is further fueled by the growth of telemedicine. The market is also heavily influenced by Europe's aging population and the corresponding increase in chronic diseases, such as cardiovascular conditions and cancer. Ultrasound's non-invasive nature and ability to provide real-time monitoring make it an ideal tool for managing these long-term conditions.

Furthermore, European healthcare systems are actively embracing technological innovation. There is a strong trend toward the integration of artificial intelligence (AI) to enhance image quality, automate measurements, and assist with diagnostic accuracy, which helps to mitigate the challenge of a shortage of skilled sonographers. While diagnostic ultrasound remains the largest segment, the therapeutic ultrasound market, particularly High-Intensity Focused Ultrasound (HIFU), is a key growth area, driven by a rising focus on non-invasive treatment options. Despite strong growth, the market faces challenges from stringent regulatory frameworks like the EU Medical Device Regulation (MDR) and pressure from price erosion, particularly in the lower-end segments due to the entry of more affordable Chinese vendors.

Asia-Pacific Ultrasound Devices Market Trends

The Asia-Pacific ultrasound devices market is poised to become the fastest-growing regional market globally, with China and Japan leading the way. This trend is driven by a unique set of factors, including a massive and aging population, rapid economic development, and increasing healthcare expenditure.

The region's healthcare landscape is characterized by a high prevalence of chronic and non-communicable diseases, such as cardiovascular diseases and cancer. This growing disease burden, coupled with increasing public awareness about early diagnosis, is creating a substantial demand for non-invasive and affordable diagnostic tools like ultrasound.

Furthermore, government initiatives aimed at improving healthcare infrastructure and accessibility in both urban and rural areas are playing a crucial role. This includes a push for domestic manufacturing of medical devices, which, particularly in China and India, is leading to the production of cost-effective ultrasound systems. This makes them more accessible to a wider patient base, especially in developing economies.

While established players like GE HealthCare and Siemens Healthineers have a strong presence, the market is also being shaped by key regional manufacturers like Mindray and Canon Medical Systems, who are known for their innovative and competitively priced products. The market is also seeing a rapid adoption of portable and handheld ultrasound devices, as they are ideal for addressing the need for point-of-care diagnostics in a region with diverse healthcare infrastructure and a large, spread-out population.

Who are the major players in the ultrasound devices market?

The following are the leading companies in the Ultrasound Devices market. These companies collectively hold the largest market share and dictate industry trends.

  • GE HealthCare
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Canon Medical Systems Corporation
  • Samsung Healthcare
  • FUJIFILM Holdings Corporation
  • Esaote SpA
  • Hologic, Inc.
  • Hitachi, Ltd
  • BPL Medical Technologies
  • SonoScape Medical Corporation
  • Butterfly Network, Inc.
  • Carestream Health
  • Clarius Mobile Health
  • Trivitron Healthcare
  • Chison Medical Imaging Co., Ltd.
  • Teratech Corporation
  • Wuhan Zoncare Bio-medical Electronics Co., Ltd.
  • SuperSonic Imagine
  • DMS Imaging
  • Others

How is the competitive landscape shaping the ultrasound devices market?

The competitive landscape of the ultrasound devices market is highly dynamic and is characterized by a moderate to high level of market concentration. It is dominated by a few major, well-established multinational corporations, often referred to as the "Big Four": GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, and Canon Medical Systems Corporation. These companies leverage their strong brand recognition, extensive global distribution networks, and substantial R&D budgets to maintain a commanding presence. GE HealthCare, for example, is estimated to hold a significant global market share, particularly due to its leadership in women's health with the Voluson series.

However, this competitive dynamic is being challenged by a new wave of innovative players. Companies like Mindray Medical International Limited and Samsung Medison are rapidly gaining market share, particularly in emerging markets, by offering a blend of advanced technology and competitive pricing. Furthermore, the rise of specialized manufacturers like FUJIFILM Sonosite and Butterfly Network is reshaping the market through their focus on portable, handheld ultrasound devices, which directly compete with the traditional cart-based systems. This has intensified competition and is driving an innovation race, compelling all players to integrate cutting-edge technologies like AI, enhanced imaging, and cloud connectivity to differentiate their products and secure their market position.

Recent Developmental Activities in the Ultrasound Devices Market

  • In August 2025, Esaote's compact platforms MyLab(TM) A50 and MyLab(TM) A70 received FDA clearance, marking their U.S. entry as battery-operated, portable systems with advanced imaging and AI features.
  • In August 2025, Philips announced the global launch of the Flash 5100 POC ultrasound system, a point-of-care device built for fast bedside use in anesthesia, ICU, emergency, and MSK settings.
  • In June 2025, Exo expanded clinical capability on its handheld Exo Iris(R) by receiving FDA 510(k) clearance for on-device AI that detects pleural effusion and consolidation, advancing AI-enabled POCUS diagnostics.
  • In May 2025, Exo Imaging and Samsung Medison announced a strategic collaboration that includes equity investment from Samsung, aimed at co-developing next-generation ultrasound platforms.
  • In April 2025, Exo added real-time Global Longitudinal Strain (GLS) analysis to the Exo Iris(R) (FDA cleared), making it the first handheld to offer on-device GLS for bedside cardiac assessment.
  • In April 2025, Philips rolled out the Elevate AI-enabled platform upgrade for its EPIQ Elite (and related Affiniti platforms), introducing automated image optimization and workflow tools to speed exams and increase diagnostic consistency.
  • In January 2025, Samsung Medison launched the premium OB/GYN system HERA / Z20 in the U.S. (debut at SMFM 2025), featuring AI tools for live quality assistance, automated labeling, and advanced fetal imaging.
  • In January 2025, Hologic finalized a $350 million acquisition of Gynesonics, the developer of the Sonata System (an ultrasound-guided system for uterine fibroid treatment).

Ultrasound Devices Market Segmentation

  • Ultrasound Devices by Product Type Exposure
  • 2D
  • 3D/4D
  • Doppler
  • High-Intensity Focused Ultrasound (HIFU)
  • Ultrasound Devices Device Display Exposure
  • Color Ultrasound
  • B/W Ultrasound
  • Ultrasound Devices Portability Exposure
  • Stationary
  • Portable
  • Ultrasound Devices Application Exposure
  • Gynecology
  • Cardiology
  • Urology
  • Orthopedic
  • Others
  • Ultrasound Devices End-Users Exposure
  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Ambulatory Surgical Centers
  • Others
  • Ultrasound Devices Geography Exposure
  • North America Ultrasound Devices Market
  • United States Ultrasound Devices Market
  • Canada Ultrasound Devices Market
  • Mexico Ultrasound Devices Market
  • Europe Ultrasound Devices Market
  • United Kingdom Ultrasound Devices Market
  • Germany Ultrasound Devices Market
  • France Ultrasound Devices Market
  • Italy Ultrasound Devices Market
  • Spain Ultrasound Devices Market
  • Rest of Europe Ultrasound Devices Market
  • Asia-Pacific Ultrasound Devices Market
  • China Ultrasound Devices Market
  • Japan Ultrasound Devices Market
  • India Ultrasound Devices Market
  • Australia Ultrasound Devices Market
  • South Korea Ultrasound Devices Market
  • Rest of Asia-Pacific Ultrasound Devices Market
  • Rest of the World Ultrasound Devices Market
  • South America Ultrasound Devices Market
  • Middle East Ultrasound Devices Market
  • Africa Ultrasound Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

The integration of artificial intelligence (AI) is a transformative force in the ultrasound devices market, fundamentally reshaping its capabilities and expanding its reach. AI-powered innovations are addressing long-standing challenges by automating time-consuming and operator-dependent tasks, which has a significant impact on workflow efficiency and accuracy. For instance, AI algorithms can automatically acquire and analyze images, freeing up clinicians to focus on patient interaction and reducing examination times.

Furthermore, AI acts as a powerful diagnostic assistant by detecting subtle anomalies and assisting in the classification of lesions, thereby improving diagnostic accuracy and reducing the risk of human error. The most profound impact of AI, however, is the democratization of ultrasound, as AI-guided systems can provide real-time, step-by-step feedback to users, empowering healthcare professionals with limited training to perform diagnostic-quality scans. This is a key driver for the explosive growth of the Point-of-Care Ultrasound (POCUS) market, extending its use to clinics, remote areas, and emergency settings. While challenges such as high costs and the need for large, high-quality datasets for training AI models exist, the future of ultrasound technology is inextricably linked with AI, which will continue to enhance its utility and redefine its role in global healthcare.

U.S. Tariff Impact Analysis on the Ultrasound Devices Market:

The implementation of U.S. tariffs, particularly on medical devices and components from China and the European Union, is creating a significant and multifaceted challenge for the global ultrasound devices market. These tariffs, which can add a considerable percentage to import costs, directly impact manufacturers by either compressing their profit margins or forcing them to pass on the added expenses to healthcare providers and, ultimately, patients. This price increase could potentially slow down the adoption of new ultrasound technology, as hospitals and clinics, especially smaller ones, may find it more difficult to afford capital-intensive equipment.

Furthermore, the tariffs are disrupting established, complex global supply chains, compelling companies to urgently find new suppliers or even consider reshoring manufacturing to avoid the added costs. This can lead to supply shortages, logistical delays, and increased operational expenses, creating market instability. While the tariffs are intended to incentivize domestic production and reduce reliance on foreign suppliers in the long term, they also pose a risk of reducing R&D spending and slowing down innovation, as companies prioritize cost management over new product development. Additionally, the possibility of retaliatory tariffs from affected countries could further harm U.S. medical device exports, adding another layer of complexity to the competitive landscape.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the ultrasound devices market report study

  • Market size analysis for the current ultrasound devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the ultrasound devices market.
  • Various opportunities available for the other competitors in the ultrasound devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current ultrasound devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the ultrasound devices market growth in the future?

Frequently Asked Questions for the Ultrasound Devices Market

1. What is the growth rate of the ultrasound devices market?

  • The ultrasound devices market is estimated to grow at a CAGR of 4.38% during the forecast period from 2025 to 2032.

2. What is the market for ultrasound devices?

  • The ultrasound devices market was valued at USD 9,315.06 million in 2024, and is expected to reach USD 13,054.68 million by 2032.

3. Which region has the highest share in the ultrasound devices market?

  • The North American ultrasound device market is dominating and growing due to its well-established healthcare infrastructure, high adoption of advanced imaging technologies, and strong presence of leading medical device manufacturers. The rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and liver diseases is driving demand for early and accurate diagnostic imaging. The region also benefits from favorable reimbursement policies, higher healthcare expenditure, and growing awareness of preventive healthcare. Continuous product innovations, such as AI-powered ultrasound and portable point-of-care systems, are further fueling adoption across hospitals and outpatient centers. In addition, the aging population and increasing use of ultrasound in women's health, cardiology, and emergency medicine are reinforcing the market's strong growth trajectory.

4. What are the drivers for the ultrasound devices market?

  • The global ultrasound device market is growing due to the rising prevalence of chronic diseases, increasing demand for early and accurate diagnosis, and the expanding use of minimally invasive procedures. Advancements in ultrasound technology, such as 3D/4D imaging, AI integration, and portable handheld systems, are further driving adoption across hospitals, diagnostic centers, and point-of-care settings. Growing awareness of prenatal care and maternal health, coupled with the aging population, has also boosted demand for ultrasound in obstetrics and cardiology. Additionally, ultrasound is cost-effective, safe, and radiation-free compared to other imaging modalities, making it a preferred diagnostic tool. Expanding healthcare infrastructure in emerging markets and favorable government initiatives to enhance access to imaging services are further contributing to market growth.

5. Who are the key players operating in the ultrasound devices market?

  • Some of the key market players operating in the ultrasound devices market include GE HealthCare, Siemens Healthineers, Canon Medical Systems Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Canon Medical Systems Corporation, Samsung Healthcare, FUJIFILM Holdings Corporation, Esaote SpA, Hologic, Inc., Hitachi, Ltd, BPL Medical Technologies, SonoScape Medical Corporation, Butterfly Network, Inc., Carestream Health, Clarius Mobile Health, Trivitron Healthcare, Chison Medical Imaging Co., Ltd., Teratech Corporation, Wuhan Zoncare Bio-medical Electronics Co., Ltd., SuperSonic Imagine, DMS Imaging, and Others.

Table of Contents

1. Ultrasound Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Ultrasound Devices Market Executive Summary

  • 2.1 Market at Glance

3. Ultrasound Devices Market Key Factors Analysis

  • 3.1 Ultrasound Devices Market Drivers
    • 3.1.1 Rising Prevalence of Chronic Diseases
    • 3.1.2 Growing Preference for Non-Invasive and Safer Diagnostics
    • 3.1.3 Advancements in Technology
    • 3.1.4 Rising Demand for Point-of-Care (POCUS)
    • 3.1.5 Expansion into Therapeutic Ultrasound
  • 3.2 Ultrasound Devices Market Restraints and Challenges
    • 3.2.1 High Cost of Advanced Ultrasound Systems
    • 3.2.2 Stringent Regulatory and Reimbursement Policies
    • 3.2.3 Challenges with Portable and Handheld Ultrasound Devices
  • 3.3 Ultrasound Devices Market Opportunity
    • 3.3.1 Integration of artificial intelligence (AI) and machine learning (ML)

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Ultrasound Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Ultrasound Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 2D
    • 7.1.2 3D/4D
    • 7.1.3 Doppler
    • 7.1.4 High-Intensity Focused Ultrasound (HIFU)
  • 7.2 By Device Display
    • 7.2.1 Color Ultrasound
    • 7.2.2 B/W Ultrasound
  • 7.3 By Portability
    • 7.3.1 Stationary
    • 7.3.2 Portable
  • 7.4 By Application
    • 7.4.1 Gynecology
    • 7.4.2 Cardiology
    • 7.4.3 Urology
    • 7.4.4 Orthopedic
    • 7.4.5 Others
  • 7.5 By End-Users
    • 7.5.1 Hospitals
    • 7.5.2 Diagnostic Centers
    • 7.5.3 Clinics
    • 7.5.4 Ambulatory Surgical Centers
    • 7.5.5 Others
  • 7.6 By Geography
    • 7.6.1 North America
      • 7.6.1.1 United States Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.1.2 Canada Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.1.3 Mexico Ultrasound Devices Market Size in USD million (2022-2032)
    • 7.6.2 Europe
      • 7.6.2.1 France Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.2 Germany Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.3 United Kingdom Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.4 Italy Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.5 Spain Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.6 Rest of Europe Ultrasound Devices Market Size in USD million (2022-2032)
    • 7.6.3 Asia-Pacific
      • 7.6.3.1 China Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.2 Japan Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.3 India Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.4 Australia Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.5 South Korea Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.6 Rest of Asia-Pacific Ultrasound Devices Market Size in USD million (2022-2032)
    • 7.6.4 Rest of the World (RoW)
      • 7.6.4.1 Middle East Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.4.2 Africa Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.4.3 South America Ultrasound Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Ultrasound Devices Market Company and Product Profiles

  • 10.1 GE HealthCare
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Siemens Healthineers
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Canon Medical Systems Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Canon Medical Systems Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Samsung Healthcare
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 FUJIFILM Holdings Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Esaote SpA
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Hologic, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Hitachi, Ltd
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 BPL Medical Technologies
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 SonoScape Medical Corporation
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Butterfly Network, Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Carestream Health
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Clarius Mobile Health
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Trivitron Healthcare
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Chison Medical Imaging Co., Ltd.
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Teratech Corporation
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Wuhan Zoncare Bio-medical Electronics Co., Ltd.
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 SuperSonic Imagine
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy
  • 10.21 DMS Imaging
    • 10.21.1 Company Overview
    • 10.21.2 Company Snapshot
    • 10.21.3 Financial Overview
    • 10.21.4 Product Listing
    • 10.21.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Ultrasound Devices Market in Global (2022-2032)
  • Table 2: Ultrasound Devices Market in Global by Product Type (2022-2032)
  • Table 3: Ultrasound Devices Market in Global by Device Display (2022-2032)
  • Table 4: Ultrasound Devices Market in Global by Portability (2022-2032)
  • Table 5: Ultrasound Devices Market in Global by Application (2022-2032)
  • Table 6: Ultrasound Devices Market in Global by End-Users (2022-2032)
  • Table 7: Ultrasound Devices Market in Global by Geography (2022-2032)
  • Table 8: Ultrasound Devices Market in North America (2022-2032)
  • Table 9: Ultrasound Devices Market in the United States (2022-2032)
  • Table 10: Ultrasound Devices Market in Canada (2022-2032)
  • Table 11: Ultrasound Devices Market in Mexico (2022-2032)
  • Table 12: Ultrasound Devices Market in Europe (2022-2032)
  • Table 13: Ultrasound Devices Market in France (2022-2032)
  • Table 14: Ultrasound Devices Market in Germany (2022-2032)
  • Table 15: Ultrasound Devices Market in United Kingdom (2022-2032)
  • Table 16: Ultrasound Devices Market in Italy (2022-2032)
  • Table 17: Ultrasound Devices Market in Spain (2022-2032)
  • Table 18: Ultrasound Devices Market in the Rest of Europe (2022-2032)
  • Table 19: Ultrasound Devices Market in Asia-Pacific (2022-2032)
  • Table 20: Ultrasound Devices Market in China (2022-2032)
  • Table 21: Ultrasound Devices Market in Japan (2022-2032)
  • Table 22: Ultrasound Devices Market in India (2022-2032)
  • Table 23: Ultrasound Devices Market in Australia (2022-2032)
  • Table 24: Ultrasound Devices Market in South Korea (2022-2032)
  • Table 25: Ultrasound Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Ultrasound Devices Market in the Rest of the World (2022-2032)
  • Table 27: Ultrasound Devices Market in the Middle East (2022-2032)
  • Table 28: Ultrasound Devices Market in Africa (2022-2032)
  • Table 29: Ultrasound Devices Market in South America (2022-2032)
  • Table 30: Competitive Landscape
  • Table 31: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Ultrasound Devices Market Drivers
  • Figure 2: Ultrasound Devices Market Restraints
  • Figure 3: Ultrasound Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in Ultrasound Devices Market
  • Figure 5: US Tariff Impact on Ultrasound Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Ultrasound Devices Market in Global (2022-2032)
  • Figure 10: Ultrasound Devices Market in Global by Product Type (2022-2032)
  • Figure 11: Ultrasound Devices Market in Global by Device Display (2022-2032)
  • Figure 12: Ultrasound Devices Market in Global by Portability (2022-2032)
  • Figure 13: Ultrasound Devices Market in Global by Application (2022-2032)
  • Figure 14: Ultrasound Devices Market in Global by End-Users (2022-2032)
  • Figure 15: Ultrasound Devices Market in Global by Geography (2022-2032)
  • Figure 16: Ultrasound Devices Market in North America (2022-2032)
  • Figure 17: Ultrasound Devices Market in the United States (2022-2032)
  • Figure 18: Ultrasound Devices Market in Canada (2022-2032)
  • Figure 19: Ultrasound Devices Market in Mexico (2022-2032)
  • Figure 20: Ultrasound Devices Market in Europe (2022-2032)
  • Figure 21: Ultrasound Devices Market in France (2022-2032)
  • Figure 22: Ultrasound Devices Market in Germany (2022-2032)
  • Figure 23: Ultrasound Devices Market in United Kingdom (2022-2032)
  • Figure 24: Ultrasound Devices Market in Italy (2022-2032)
  • Figure 25: Ultrasound Devices Market in Spain (2022-2032)
  • Figure 26: Ultrasound Devices Market in the Rest of Europe (2022-2032)
  • Figure 27: Ultrasound Devices Market in Asia-Pacific (2022-2032)
  • Figure 28: Ultrasound Devices Market in China (2022-2032)
  • Figure 29: Ultrasound Devices Market in Japan (2022-2032)
  • Figure 30: Ultrasound Devices Market in India (2022-2032)
  • Figure 31: Ultrasound Devices Market in Australia (2022-2032)
  • Figure 32: Ultrasound Devices Market in South Korea (2022-2032)
  • Figure 33: Ultrasound Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 34: Ultrasound Devices Market in the Rest of the World (2022-2032)
  • Figure 35: Ultrasound Devices Market in the Middle East (2022-2032)
  • Figure 36: Ultrasound Devices Market in Africa (2022-2032)
  • Figure 37: Ultrasound Devices Market in South America (2022-2032)
  • Figure 38: Competitive Landscape
  • Figure 39: Startup Funding & Investment Trends